Edition:
United Kingdom

MorphoSys AG (MORG.DE)

MORG.DE on Xetra

111.50EUR
20 Aug 2019
Change (% chg)

-- (--)
Prev Close
€111.50
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
150,408
52-wk High
€114.60
52-wk Low
€76.45

Select another date:

Wed, Aug 7 2019

CORRECTED-BRIEF-Morphosys Confirms Higher 2019 Revenue Guidance

* Financial year 2019 guidance, updated in July, confirmed: revenues in range of 65 mln to 72 mln eur

BRIEF-Galapagos, MorphoSys Announce Initiation Of Gecko Phase 2 Study

* GECKO IS A PHASE 2 STUDY TESTING A SUBCUTANEOUS FORMULATION OF MOR106 IN COMBINATION WITH TOPICAL CORTICOSTEROIDS IN PATIENTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS

German biotech group Morphosys seeks European partner for debut drug

FRANKFURT, Feb 25 German biotech firm Morphosys is in talks with potential partners to bring its debut drug, a therapeutic antibody against leukaemia, to Europe.

Select another date: